Impact Factor
3.59
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.70
500 total citations
h5-index
29
h5 depth signal
Cited share
77.7%
108 of 139
Total citations
500
Citation footprint
Metric signal
4.80
External metric anchor
Self-citation
0.8%
4 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
199
Iran
124
United Kingdom
98
China
57
Pakistan
50
Citing Fields of Research
Diabetes
533
Endocrinology & Metabolism
148
Nutrition & Dietetics
70
Hepatitis
39
Cardiology
38
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
842
Articles tracked across the journal lifetime
Indexed publication set
139
108 cited publications
Last 12 months
226
18.8 publications/month
Open access share
100.0%
226 OA publications in the last year
Leading citing country
United States
199 citing publications
Leading citing field
Diabetes
533 citing publications
Latest tracked publication
16 October 2026
10 recent records available
Coverage & Indexing History
v4n1, Jan. 2021-
v1n1, 2018-
Active Coverage
Research Focus & Classification
Indexed Subjects
Diabetes
Broad Categories
Endocrinology
Metabolism
Diabetes
Endocrinology & Metabolism
Hepatitis
Nutrition & Dietetics
Human Reproduction
MeSH Descriptors
Diabetes Mellitus
Endocrine System Diseases
Endocrine System
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1002/edm2.70360
Open DOI
Metabolic Changes During a Calorie‐Restricted, Fish‐Rich Ketogenic Diet Associated With Increased Circulating TMAO in Healthy Adults
Background: A ketogenic diet (KD) is increasingly investigated as a nutritional approach for improving glycemic control and metabolic health. However, relatively few studies have examined fish‐rich ketogenic interventions. Fish consumpti...
02
DOI 10.1002/edm2.70332
Open DOI
Real‐World Metabolic Improvements in Women With and Without Polyendocrine Metabolic Syndrome via a Multidisciplinary Telehealth Care Platform
Objective: To evaluate metabolic outcomes in women with and without Polyendocrine Metabolic Ovarian Syndrome (PMOS, formerly Polycystic Ovary Syndrome (PCOS))) receiving multidisciplinary care through a women's health telehealth platform...
03
DOI 10.1002/edm2.70364
Open DOI
Liraglutide Dose Affordability and Durability in Real‐World Obesity Care
04
DOI 10.1002/edm2.70358
Open DOI
Efficacy and Safety of Enlicitide in Hypercholesterolemia: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
Background: Atherosclerotic cardiovascular disease remains a leading cause of global mortality, with low‐density lipoprotein cholesterol (LDL‐C) reduction being the cornerstone of prevention. Despite effective therapies, many high‐risk p...
05
06
DOI 10.1002/edm2.70343
Open DOI
Gene‐Guided Therapy in Type 2 Diabetes Mellitus: An Integrative Review of the Pharmacogenetics of Metformin and Sodium‐Glucose Cotransporter‐2 Inhibitors
Background: Inter‐individual variability in the therapeutic response to antidiabetic drugs is still a big problem in the management of type 2 diabetes mellitus (T2DM). Genetic polymorphisms of drug transporters, metabolizing enzymes and ...
07
DOI 10.1002/edm2.70349
Open DOI
Diabetic Autonomic Neuropathy and Impaired Inflammatory Reflex
Introduction: Diabetes mellitus is increasingly recognised as a chronic metabolic‐inflammatory disorder. Diabetic autonomic neuropathy (DAN) is a prevalent yet underdiagnosed complication associated with significant morbidity and mortali...
08
DOI 10.1002/edm2.70355
Open DOI
Impact of Evolocumab on LDL‐Cholesterol and Cardiovascular Outcomes in Patients With Established CVD: Systematic Review and Meta‐Analysis
Background: Atherosclerotic cardiovascular disease is a leading cause of morbidity and mortality, and many high‐risk patients fail to reach LDL‐cholesterol (LDL‐C) targets on statins alone. Evolocumab, a PCSK9 inhibitor, offers potent LD...
09
DOI 10.1002/edm2.70350
Open DOI
Comparison of Clinical, Metabolic, and Hormonal Profiles in Obese Versus Lean Women With Polycystic Ovary Syndrome: A Systematic Review and Meta‐Analysis
Introduction: Obesity substantially influences clinical and metabolic manifestations of polycystic ovary syndrome (PCOS). However, differences in clinical, metabolic, and hormonal profiles between obese and lean women with PCOS have not ...
10
DOI 10.1002/edm2.70347
Open DOI
Glycaemic Variability and C‐Peptide in Bangladeshi Children, Adolescents, and Young Adults With Diabetes: A Prospective Study
Objectives: To characterise the magnitude of glycaemic variability and to examine the factors associated with it, with particular attention to residual beta‐cell function measured by fasting C‐peptide, in children, adolescents, and young...
Bibliographical & Catalog Notes
Some articles in v. 1 published electronically in 2017.